23 April 2019

Bayer Launches New Redoxon Triple Action Supplement to Overcome Immunity Challenges during Ramadhan Fasting Period

JAKARTA, Indonesia, April 23, 2019 – Immunity challenges are commonly experienced during fasting period in the Ramadhan month, due to low nutrition intake while doing the same level of activities. Our body immunity is affected and the risk of getting sick increases, if this is not balanced by high-quality nutritional intake with sufficient micronutrients like vitamins and minerals. Therefore, consuming both balanced nutrition and supplements, during Suhoor is the key to maintaining body immunity system during fasting period.

This topic is brought up in the discussion during launch of new Redoxon Triple Action, a leading immunity supplement brand from Bayer. The launch event was attended by Maudy Ayunda, a public figure and brand ambassador of Redoxon, Kinshuk Kunwar, Director of PT Bayer Indonesia and Dr. Suci Sutinah Diah Suksmasari, Medical Advisor of PT Bayer Indonesia.

“Ramadhan is a special month for Moslems throughout the world. Bayer is launching Redoxon Triple Action Supplement to support the fasting effort, so that fasting Indonesians can stay healthy, active and can fully participate in all Ramadhan related activities ” said Kinshuk Kunwar, Director PT Bayer Indonesia.

“In anticipation of inadequate nutritional intake during fasting, our body needs extra nutritional intake of vitamins and minerals. The new Redoxon Triple Action contains high levels of Vitamin C, Vitamin D and Zinc, to support the three layers of body’s immunity defence" added Dr. Suci Sutinah Diah Suksmasari, Medical Advisor, PT Bayer Indonesia.

Running a variety of activities while fasting and understanding that Suhoor intake has a big influence on her during Ramadan, Maudy Ayunda, public figure and Redoxon brand ambassador stated, "The full schedule of activities encouraged me to stay healthy. Welcoming Ramadan, I surely have to pay more attention on body immunity. Consuming Redoxon Triple Action every Suhoor, helps my body to be ready for fasting and remain strong in carrying out the daily activities, and also Ramadan routine"

About Redoxon
Each of Redoxon Triple Action tablet contains 1,000 mg of vitamin C (which is equal to total vitamin C in 40 oranges), 400 IU of vitamin D, and 10 mg of Zinc. With the combination and synergistic effect of the three micronutrients, each of Redoxon Triple Action tablet also helps fight micronutrient deficiencies - including while fasting, and helps maintain antioxidant levels within the body so that the body's immune can functioned normally.

Redoxon Triple Action is available in 2 flavours - Orange and Blackcurrant, which comes in tubes containing 10 tablets, 20 tablets and strips of 2 tablets. For this years Ramadan, Redoxon Triple Action provides an extra 50% with 10 + 5 tablets free. All Redoxon variants can be purchased at various pharmacies and drug stores across Indonesia, as well as Bayer Health Official Partners stores in leading e-commerce platforms such as Shopee, Lazada, JD.ID, Tokopedia, and Bukamart.

# # #

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2018, the Group employed around 117,000 people and had sales of 39.6 billion euros. Capital expenditures amounted to 2.6 billion euros, R&D expenses to 5.2 billion euros. For more information, go to www.bayer.com.

Contact for Media:
Laksmi Prasvita, phone +62 21 3049-1490
Email: laksmi.prasvita@bayer.com
For more information please visit www.bayer.co.id or www.bayer.com

Forward-looking statements
This press release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors can cause material differences between actual future results, financial situation, development or company performance and forecasts given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company is not responsible for renewing this forward-looking statement or for adjusting it for future events or developments.

Online press services can be accessed at: www.bayer.co.id/id/media

Follow us on Facebook: www.facebook.com/bayerindonesia